menu
    • menu

    Company profile for PolyPid

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the...
    We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the body over days to several months in a controlled manner.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PolyPidIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    18 Hasivim Street, P.O Box 7126 Petach Tikva, Israel 4959376
    Telephone
    Telephone
    +972-74-719-5700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.polypid.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/polypid
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Polypid Initiates D-PLEX??? NDA Submission To The FDA
    Polypid Initiates D-PLEX??? NDA Submission To The FDA

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265508/0/en/PolyPid-Initiates-D-PLEX-NDA-Submission-to-the-FDA.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Polypid Granted FDA PDUFA Fee Waiver For D-Plex??? NDA
    Polypid Granted FDA PDUFA Fee Waiver For D-Plex??? NDA

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257177/0/en/PolyPid-Receives-PDUFA-Fee-Waiver-from-FDA-for-D-PLEX-s-New-Drug-Application.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Polypid Announces Participation In Upcoming Investor Conferences
    Polypid Announces Participation In Upcoming Investor Conferences

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244614/0/en/PolyPid-Announces-Participation-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Polypid Reports Q4 and Full-Year 2025 Results
    Polypid Reports Q4 and Full-Year 2025 Results

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236172/0/en/PolyPid-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    PolyPid to Report Q4 2025 Results on Feb. 11, 2026
    PolyPid to Report Q4 2025 Results on Feb. 11, 2026

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227536/0/en/PolyPid-to-Report-Fourth-Quarter-2025-Financial-Results-and-Operational-Highlights-on-February-11-2026.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    Polypid Names Brooke Story Chairman Of Board of Directors
    Polypid Names Brooke Story Chairman Of Board of Directors

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206217/0/en/PolyPid-Appoints-Veteran-MedTech-Leader-Brooke-Story-as-Chairman-of-the-Board-of-Directors.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search